E-LIB Suche - Ergebnisse für: Laufer, Stefan

1

Targeting Lewy body dementia with neflamapimod‐rasagiline h..:

Albertini, Claudia ; Petralla, Sabrina ; Massenzio, Francesca...
Archiv der Pharmazie. 357 (2024) 6 - p. , 2024

2

Development of Highly Potent and Selective Covalent FGFR4 I..:

Schwarz, Moritz ; Kurkunov, Maksym ; Wittlinger, Florian...
Journal of Medicinal Chemistry. 67 (2024) 8 - p. 6549-6569 , 2024

Link: https://doi.org/10.1021/..

3

HDAC specificity and kinase off-targeting by purine-benzohy..:

Waitman, Karoline B. ; de Almeida, Larissa C. ; Primi, Marina C....
European Journal of Medicinal Chemistry. 263 (2024) - p. 115935 , 2024

Link: https://doi.org/10.1016/..

4

Towards a zero-waste sustainable biorefinery of Codium sp. ..:

Martins, Alice ; Silva, Joana ; Alves, Celso...
Journal of Cleaner Production. 453 (2024) - p. 142191 , 2024

Link: https://doi.org/10.1016/..

5

Toward more sustainable enzyme reactions: enhancing kinetic..:

Rentschler, Simone ; Borgolte, Max ; Csuk, René..
Green Chemistry. 26 (2024) 3 - p. 1653-1659 , 2024

Link: https://doi.org/10.1039/..

6

Journal of Medicinal Chemistry Collection: Drug Discovery i..:

Laufer, Stefan ; Gehringer, Matthias ; Titz, Alexander
Journal of Medicinal Chemistry. 67 (2024) 4 - p. 2237-2237 , 2024

Link: https://doi.org/10.1021/..

7

The molecular interaction pattern of lenvatinib enables inh..:

Spahn, Stephan ; Kleinhenz, Fabian ; Shevchenko, Ekaterina...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: D..:

Flury, Philipp ; Breidenbach, Julian ; Krüger, Nadine...
ACS Pharmacology & Translational Science. 7 (2024) 4 - p. 1195-1196 , 2024

Link: https://doi.org/10.1021/..

9

Linking ATP and allosteric sites to achieve superadditive b..:

Wittlinger, Florian ; Ogboo, Blessing C. ; Shevchenko, Ekaterina...
Communications Chemistry. 7 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

10

Ready-to-use nanopore platform for label-free small molecul..:

Quint, Isabel ; Simantzik, Jonathan ; Kaiser, Lars...
Nanomedicine: Nanotechnology, Biology and Medicine. 55 (2024) - p. 102724 , 2024

Link: https://doi.org/10.1016/..

11

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesi..:

Flury, Philipp ; Breidenbach, Julian ; Krüger, Nadine...
ACS Pharmacology & Translational Science. 7 (2024) 2 - p. 493-514 , 2024

Link: https://doi.org/10.1021/..

12

Small-molecule inhibition of MAP2K4 is synergistic with RAS..:

Jansen, Robin A. ; Mainardi, Sara ; Dias, Matheus Henrique...
Proceedings of the National Academy of Sciences. 121 (2024) 9 - p. , 2024

Link: https://doi.org/10.1073/..

13

Influence of design parameters on sustained drug release pr..:

Pflieger, Thomas ; Venkatesh, Rakesh ; Dachtler, Markus...
International Journal of Pharmaceutics. 658 (2024) - p. 124207 , 2024

Link: https://doi.org/10.1016/..

14

Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3..:

Riester, Oliver ; Kaiser, Lars ; Laufer, Stefan.
Advanced Science. 11 (2024) 21 - p. , 2024

Link: https://doi.org/10.1002/..

15

Selective Inhibitors of Janus Kinase 3 Modify Responses to ..:

Laux, Julian ; Martorelli, Mariella ; Späth, Nadja...
ACS Pharmacology & Translational Science. 6 (2023) 6 - p. 892-906 , 2023

Link: https://doi.org/10.1021/..